Share-based Payment Arrangement, Expense of Disc Medicine, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Disc Medicine, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Disc Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $9,514,000, a 120% increase year-over-year.
  • Disc Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $28,631,000, a 99% increase year-over-year.
  • Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $16,815,000, a 204% increase from 2023.
  • Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5,530,000, a 165% increase from 2022.
  • Disc Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2,089,000, a 312% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Disc Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $28,631,000 $9,514,000 +$5,182,000 +120% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $23,449,000 $8,420,000 +$4,329,000 +106% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $19,120,000 $6,363,000 +$2,305,000 +57% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $16,815,000 $4,334,000 +$2,407,000 +125% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $14,408,000 $4,332,000 +$3,062,000 +241% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $11,346,000 $4,091,000 +$2,782,000 +213% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $8,564,000 $4,058,000 +$3,034,000 +296% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $5,530,000 $1,927,000 +$934,000 +94% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $4,596,000 $1,270,000 +$888,000 +232% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $3,708,000 $1,309,000 +$927,000 +243% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $2,781,000 $1,024,000 +$692,000 +208% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $2,089,000 $993,000 +$6,600,000 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $4,511,000 $382,000 -$1,277,000 -77% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $3,234,000 $382,000 -$2,480,000 -87% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $754,000 $332,000 -$1,261,000 -79% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $507,000 $5,607,000 -$6,197,000 -1050% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $6,704,000 $1,659,000 +$1,498,000 +930% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $5,206,000 $2,862,000 +$2,724,000 +1974% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $2,482,000 $1,593,000 +$1,499,000 +1595% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $983,000 $590,000 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $161,000 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $138,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $94,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

Disc Medicine, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $16,815,000 +$11,285,000 +204% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $5,530,000 +$3,441,000 +165% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $2,089,000 +$1,582,000 +312% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $507,000 -$476,000 -48% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $983,000 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.